CoChat
Sign Up
Cited by 221

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

An Overview of the Evidence and Mechanisms of Herb–Drug Interactions

Fasinu, Pius S., Bouic, Patrick J., Rosenkranz, Bernd·2012·Frontiers in Pharmacology
DOI 10.3389/fphar.2012.00069PMC PMC3339338
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2012.00069

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HILI-specific risk factors include quality of products, identical names but different substances, counterfeit drug misuse, mixing or adulteration, environmental contaminants, unreasonable or incompatible formulation, and irrational use of HDS.

    “However, the following HILI-specific risk factors may cause liver injury [126-133]: (1) quality of products: different places of origin and improper preparation may cause differences in components, thereby increasing the risk of hepatotoxicity; (2) identical names but different substances, counterfeit drug misuse, mixing, or adulteration; (3) environmental contaminants, such as pesticide residues,”

    From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [129]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 262

  1. Abii T. A. Onuoha E. N. (2011). The chemical constituents of the leaf of Aspilia africana as a scientific backing to its tradomedical potentials. Agric. J. 6, 28– 30 10.3923/aj.2011.28.30 · DOI
  2. Agrosi M. Mischatti S. Harrasser P. C. Savio D. (2000). Oral bioavailability of active principles from herbal products in humans: a study on Hypericum perforatum extracts using the soft gelatin capsule technology. Phytomedicine 7, 455– 462 10.1016/S0944-7113(00)80029-X 11194173 · DOI
  3. Ajayi A. A. Newaz M. Hercule H. Saleh M. Bode C. O. Oyekan A. O. (2003). Endothelin-like action of Pausinystalia yohimbe aqueous extract on vascular and renal regional hemodynamics in Sprague Dawley rats. Methods Find. Exp. Clin. Pharmacol. 25, 817– 822 10.1358/mf.2003.25.10.793331 14735230 · DOI
  4. Al-Ali M. Wahbi S. Twaij H. Al-Badr A. (2003). Tribulus terrestris: preliminary study of its diuretic and contractile effects and comparison with Zea mays. J. Ethnopharmacol. 85, 257– 260 12639749
  5. Albert A. Altabre C. Baró F. Buendía E. Cabero A. Cancelo M. J. Castelo-Branco C. Chantre P. Duran M. Haya J. Imbert P. Julía D. Lanchares J. L. Llaneza P. Manubens M. Miñano A. Quereda F. Ribes C. Vázquez F. (2002). Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology: a multicentric, open, prospective and non-randomized trial. Phytomedicine 9, 85– 92 10.1078/0944-7113-00107 11995954 · DOI
  6. Al-Deeb I. D. Arafat T. A. Irshaid Y. M. (2010). The effect of Licorice drink on the systemic exposure of Verapamil in rabbits. Drug Metab. Lett. 4, 173– 179 10.2174/187231210791698474 20642450 · DOI
  7. Al-Habori M. (2005). The potential adverse effects of habitual use of Catha edulis (khat). Expert Opin. Drug Saf. 4, 1145– 1154 10.1517/14740338.4.6.1145 16255671 · DOI
  8. Alkharfy K. M. Frye R. F. (2007). Effect of valerian, valerian/hops extracts, and valerenic acid on glucuronidation in vitro. Xenobiotica 37, 113– 123 10.1080/00498250601050420 17484515 · DOI
  9. Alvarez A. I. Real R. Perez M. Mendoza G. Prieto J. G. Merino G. (2010). Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J. Pharm. Sci. 99, 598– 617 19544374
  10. Amacher D. E. (2010). The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in pre-clinical safety studies. Toxicol. Mech. Methods 20, 159– 166 10.3109/15376511003690307 20218941 · DOI
  11. Armanini D. Fiore C. Mattarello M. J. Bielenberg J. Palermo M. (2002). History of the endocrine effects of Licorice. Exp. Clin. Endocrinol. Diabetes 110, 257– 261 10.1055/s-2002-34587 12373628 · DOI
  12. Arteaga I. Andrade-Cetto A. Cárdenas R. (2005). Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid. J. Ethnopharmacol. 98, 231– 239 10.1016/j.jep.2005.02.002 15814253 · DOI
  13. Asdaq S. M. Inamdar M. N. (2010). Pharmacodynamic interaction of captopril with garlic in isoproterenol-induced myocardial damage in rat. Phytother. Res. 24, 720– 725 19830688
  14. Asdaq S. M. Inamdar M. N. Asad M. (2009). Effect of conventional antihypertensive drugs on hypolipidemic action of garlic in rats. Indian J. Exp. Biol. 47, 176– 181 19405382
  15. Ashihara H. Crozier A. (2001). Caffeine: a well-known but little mentioned compound in plant science. Trends Plant Sci. 6, 407– 413 10.1016/S1360-1385(01)02055-6 11544129 · DOI
  16. Aungst B. J. (2000). Intestinal permeation enhancers. J. Pharm. Sci. 89, 429– 442 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J 10737905 · DOI
  17. Ayuba V. O. Ofojekwu P. C. (2005). “Effects of extracts of dried seeds of toloache, Datura innoxia as anaesthesia on the African catfish Clarias gariepinus fingerlings,” in 19th Annual Conference of the Fisheries Society of Nigeria Available at: http://aquaticcommons.org/3986/1/25.pdf [accessed November 03, 2011].
  18. Bafna A. Mishra S. (2010). Antioxidant and immunomodulatory activity of the alkaloidal fraction of Cissampelos pareira linn. Sci. Pharm. 78, 21– 31 10.3797/scipharm.1011-10 21179368 PMC3002827 · DOI
  19. Balderas J. L. Reza V. Ugalde M. Guzmán L. Serrano M. I. Aguilar A. Navarrete A. (2008). Pharmacodynamic interaction of the sedative effects of Ternstroemia pringlei (Rose) Standl. with six central nervous system depressant drugs in mice. J. Ethnopharmacol. 119, 47– 52 10.1016/j.jep.2008.05.035 18582555 · DOI
  20. Baquer N. Z. Kumar P. Taha A. Kale R. K. Cowsik S. M. McLean P. (2011). Metabolic and molecular action of Trigonella foenum-graecum (fenugreek) and trace metals in experimental diabetic tissues. J. Biosci. 36, 383– 396 10.1007/s12038-011-9042-0 21654091 · DOI
  21. Barbenel D. M. Yusufi B. O’Shea D. Bench C. J. (2000). Mania in a patient receiving testosterone replacement postorchidectomy taking St John’s wort and sertraline. J. Psychopharmacol. 14, 84– 86 10.1177/026988110001400113 10757260 · DOI
  22. Barnes J. Anderson L. A. Gibbons S. Phillipson J. D. (2005). Echinacea species (Echinacea angustifolia (DC.) Hell, Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench: a review of their chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 57, 929– 954 16102249
  23. Bebawy M. Sze D. M. (2008). Targeting P-glycoprotein for effective oral anti-cancer chemotherapeutics. Curr. Cancer Drug Targets 8, 47– 52 10.2174/156800908783497168 18288943 · DOI
  24. Bensoussan A. Myers S. P. Wu S. M. O’Connor K. (2004). Naturopathic and Western herbal medicine practice in Australia – a workforce survey. Complement. Ther. Med. 12, 17– 27 10.1016/S0965-2299(04)00077-9 15130568 · DOI
  25. Berginc K. Kristl A. (2012). The effect of garlic supplements and phytochemicals on the ADMET properties of drugs. Expert Opin. Drug Metab. Toxicol. 8, 295– 310 10.1517/17425255.2012.659662 22313151 · DOI
  26. Bihl G. Meyers A. (2001). Recurrent renal stone disease – advances in pathogenesis and clinical management. Lancet 358, 651– 656 10.1016/S0140-6736(01)05782-8 11530173 · DOI
  27. Bilgi N. Bell K. Ananthakrishnan A. N. Atallah E. (2010). Imatinib and Panax ginseng: a potential interaction resulting in liver toxicity. Ann. Pharmacother. 44, 926– 928 10.1345/aph.1M715 20332334 · DOI
  28. Birmes P. Coppin D. Schmitt L. Lauque D. (2003). Serotonin syndrome: a brief review. CMAJ 168, 1439– 1442 12771076 PMC155963
  29. Bodeker G. (2007). Traditional health systems: policy, biodiversity, and global interdependence. J. Altern. Complement. Med. 1, 231– 243 10.1089/acm.1995.1.231 9395619 · DOI
  30. Bonetto N. Santelli L. Battistin L. Cagnin A. (2007). Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum. Cephalalgia 27, 1421– 1423 10.1111/j.1468-2982.2007.01430.x 17868285 · DOI
  31. Borrel M. N. Pereira E. Fiallo M. Garnier-Suillerot A. (1994). Mobile ionophores are a novel class of P-glycoprotein inhibitors. The effects of ionophores on 4′-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells. Eur. J. Biochem. 223, 125– 133 10.1111/j.1432-1033.1994.tb18973.x 7518390 · DOI
  32. Borrelli F. Izzo A. A. (2009). Herb-drug interactions with St John’s wort (Hypericum perforatum): an update on clinical observations. AAPS J. 11, 710– 727 10.1208/s12248-009-9146-8 19859815 PMC2782080 · DOI
  33. Bosch T. M. (2008). Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy. Methods Mol. Biol. 448, 63– 76 10.1007/978-1-59745-205-2_5 18370231 · DOI
  34. Boucher B. J. Mannan N. (2002). Metabolic effects of the consumption of Areca catechu. Addict. Biol. 7, 103– 110 10.1080/13556210120091464 11900629 · DOI
  35. Boullata J. I. Nace A. M. (2000). Safety issues with herbal medicine. Pharmacotherapy 20, 257– 269 10.1592/phco.20.4.257.34886 10730682 · DOI
  36. Bray B. J. Perry N. B. Menkes D. B. Rosengren R. J. (2002). St John’s wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse. Toxicol. Sci. 66, 27– 33 10.1093/toxsci/66.1.27 11861970 · DOI
  37. Brown L. Heyneke O. Brown D. van Wyk J. P. Hamman J. H. (2008). Impact of traditional medicinal plant extracts on antiretroviral drug absorption. J. Ethnopharmacol. 119, 588– 592 10.1016/j.jep.2008.06.028 18640255 · DOI
  38. Calixto J. B. (2000). Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz. J. Med. Biol. Res. 33, 179– 189 10.1590/S0100-879X2000000200004 10657057 · DOI
  39. Cassidy A. (2003). Are herbal remedies and dietary supplements safe and effective for breast cancer patients? Breast Cancer Res. 5, 300– 302 10.1186/bcr724 14580245 PMC314418 · DOI
  40. Chan T. Y. (2001). Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann. Pharmacother. 35, 501– 504 10.1345/aph.19029 11302416 · DOI
  41. Chao M. T. Wade C. Kronenberg F. (2008). Disclosure of complementary and alternative medicine to conventional medical providers: variation by race/ethnicity and type of CAM. J. Natl. Med. Assoc. 100, 1341– 1349 19024232 PMC2709648
  42. Chen C. L. Fang H. C. Chou K. J. Wang J. S. Chung H. M. (2001). Acute oxalate nephropathy after ingestion of star fruit. Am. J. Kidney Dis. 37, 418– 422 10.1053/ajkd.2001.21333 11157385 · DOI
  43. Cheng B. Hung C. T. Chiu W. (2002). Herbal medicine and anaesthesia. Hong Kong Med. J. 8, 123– 130 11937667
  44. Chitturi S. Farrell G. C. (2000). Herbal hepatotoxicity: an expanding but poorly defined problem. J. Gastroenterol. Hepatol. 15, 1093– 1099 10.1046/j.1440-1746.2000.02349.x 11106086 · DOI
  45. Chitturi S. Farrell G. C. (2008). Hepatotoxic slimming aids and other herbal hepatotoxins. J. Gastroenterol. Hepatol. 23, 366– 373 10.1111/j.1440-1746.2008.05310.x 18318821 · DOI
  46. Choi J. S. Burm J. P. (2006). Enhanced nimodipine bioavailability after oral administration of nimodipine with morin, a flavonoid, in rabbits. Arch. Pharm. Res. 29, 333– 338 10.1007/BF02968586 16681041 · DOI
  47. Circosta C. Pasquale R. D. Palumbo D. R. Samperi S. Occhiuto F. (2006). Estrogenic activity of standardized extract of Angelica sinensis. Phytother. Res. 20, 665– 669 10.1002/ptr.2017 16691630 · DOI
  48. Clement Y. N. Williams A. F. Khan K. Bernard T. Bhola S. Fortuné M. Medupe O. Nagee K. Seaforth C. E. (2005). A gap between acceptance and knowledge of herbal remedies by physicians: the need for educational intervention. BMC Complement. Altern. Med. 5, 20 10.1186/1472-6882-5-20 16297236 PMC1310610 · DOI
  49. Colalto C. (2010). Herbal interactions on absorption of drugs: mechanisms of action and clinical risk assessment. Pharmacol. Res. 62, 207– 227 10.1016/j.phrs.2010.04.001 20399862 · DOI
  50. Coppola M. Mondola R. (2012). Potential action of betel alkaloids on positive and negative symptoms of schizophrenia: a review. Nord. J. Psychiatry 66, 73– 78 10.3109/08039488.2011.605172 21859398 · DOI
  51. Cordia W. Steenkamp V. (2011). Drug interactions in African herbal remedies. Drug Metabol. Drug Interact. 26, 53– 63 10.1515/dmdi.2011.011 21756221 · DOI
  52. Cox M. C. Low J. Lee J. Walshe J. Denduluri N. Berman A. Permenter M. G. Petros W. P. Price D. K. Figg W. D. Sparreboom A. Swain S. M. (2006). Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel. Clin. Cancer Res. 12, 4636– 4640 10.1158/1078-0432.CCR-06-0388 16899612 · DOI
  53. Crijns A. P. se Smet P. A. van den Heuvel M. Schot B. W. Haagsma E. B. (2002). Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus). Ned. Tijdschr. Geneeskd. 19, 124– 128 11826672
  54. Crosby E. C. Dolan R. L. Benson J. E. Luetkemeier M. J. Barton R. G. Askew E. W. (2001). Herbal diuretic induced dehydration and resting metabolic rate. Med. Sci. Sports Exerc. 33, S163 10.1097/00005768-200105001-00923 · DOI
  55. Cullen J. M. (2005). Mechanistic classification of liver injury. Toxicol. Pathol. 33, 6– 8 10.1080/01926230590522428 15805050 · DOI
  56. Dannawi M. (2002). Possible serotonin syndrome after combination of buspirone and St John’s wort. J. Psychopharmacol. (Oxford) 16, 401 10.1177/026988110201600421 12503845 · DOI
  57. Dasgupta A. Kidd L. Poindexter B. J. Bick R. J. (2010). Interference of hawthorn on serum digoxin measurements by immunoassays and pharmacodynamic interaction with digoxin. Arch. Pathol. Lab. Med. 134, 1188– 1192 20670141
  58. De Almeida E. R. Melo A. M. Xavier H. (2000). Toxicological evaluation of the hydro-alcohol extract of the dry leaves of Peumus boldus and boldine in rats. Phytother. Res. 14, 99– 102 10.1002/(SICI)1099-1573(200003)14:2<99::AID-PTR600>3.0.CO;2-4 10685105 · DOI
  59. De Berardinis V. Moulis C. Maurice M. Beaune P. Pessayre D. Pompon D. Loeper J. (2000). Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol. Pharmacol. 3, 542– 551 10953047
  60. De Maat M. M. Hoetelmans R. M. W. Mathôt R. A. van Gorp E. C. Meenhorst P. L. Mulder J. W. Beijnen J. H. (2001). Drug interactions between St John’s wort and nevirapine. AIDS 15, 420– 421 10.1097/00002030-200102160-00019 11273226 · DOI
  61. Dearing D. M. Mangione A. M. Karasov W. H. (2001). Plant secondary compounds as diuretics: an overlooked consequence. Am. Zool. 41, 890– 901 10.1668/0003-1569(2001)041[0890:PSCADA]2.0.CO;2 · DOI
  62. Déciga-Campos M. Rivero-Cruz I. Arriaga-Alba M. Castañeda-Corral G. Angeles-López G. E. Navarrete A. Mata R. (2007). Acute toxicity and mutagenic activity of Mexican plants used in traditional medicine. J. Ethnopharmacol. 110, 334– 342 10.1016/j.jep.2006.10.001 17101253 · DOI
  63. Degorter M. K. Xia C. Q. Yang J. J. Kim R. B. (2012). Drug transporters in drug efficacy and toxicity. Annu. Rev. Pharmacol. Toxicol. 52, 249– 273 10.1146/annurev-pharmtox-010611-134529 21942630 · DOI
  64. DeLeve L. D. Schulman H. M. MacDonald G. B. (2002). Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin. Liver Dis. 22, 27– 42 10.1055/s-2002-23204 11928077 · DOI
  65. Delgoda R. Westlake A. C. G. (2004). Herbal interactions involving cytochrome P450 enzymes: a mini review. Toxicol. Rev. 23, 239– 249 10.2165/00139709-200423040-00004 15898829 · DOI
  66. Di Y. M. Li C. G. Xue C. C. Zhou S. F. (2008). Clinical drugs that interact with St. John’s wort and implication in drug development. Curr. Pharm. Des. 14, 1723– 1742 10.2174/138161208784746798 18673195 · DOI
  67. Dresser G. K. Schwarz U. I. Wilkinson G. R. Kim R. B. (2007). Coordinate induction of both cytochrome P4503A and MDR1 by St John’s wort in healthy subjects. Clin. Pharmacol. Ther. 73, 41– 50 10.1067/mcp.2003.10 12545142 · DOI
  68. Durazo F. A. Lassman C. Han S. H. Saab S. Lee N. P. Kawano M. Saggi B. Gordon S. Farmer D. G. Yersiz H. Goldstein R. L. Ghobrial M. Busuttil R. W. (2004). Fulminant liver failure due to usnic acid for weight loss. Am. J. Gastroenterol. 5, 950– 952 10.1111/j.1572-0241.2004.04165.x 15128366 · DOI
  69. Eichhorn T. Efferth T. (2011). Pglycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbal medicine. J. Ethnopharmacol. [Epub ahead of print]. 10.1016/j.jep.2011.08.053 21963565 · DOI
  70. Emilio L. Ghisalberti E. L. Pennacchio M. Alexander E. (1998). Survey of secondary plant metabolites with cardiovascular activity. Pharm. Biol. 36, 237– 279 10.1076/phbi.36.4.237.4583 · DOI
  71. Emma C. (2008). Lycopodium similiaplex-induced acute hepatitis: a case report. Eur. J. Gastroenterol. Hepatol. 20, 469– 471 10.1097/MEG.0b013e3282f1623d 18403950 · DOI
  72. Engelberg D. McCutcheon A. Wiseman S. (2001). A case of ginseng-induced mania. J. Clin. Psychopharmacol. 21, 535– 537 10.1097/00004714-200110000-00015 11593083 · DOI
  73. Ernst E. (2002). St John’s wort supplements endanger the success of organ transplantation. Arch. Surg. 137, 316– 319 10.1001/archsurg.137.3.316 11888457 · DOI
  74. Ernst E. (2004). Are herbal medicines effective? Int. J. Clin. Pharmacol. Ther. 42, 157– 159 15049435
  75. Ernst E. (2005). The efficacy of herbal medicine – an overview. Fundam. Clin. Pharmacol. 19, 405– 409 10.1111/j.1472-8206.2005.00335.x 16011726 · DOI
  76. Fabricant D. S. Farnsworth N. R. (2001). The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 109, 69– 75 10.1289/ehp.109-a69 11250806 PMC1240543 · DOI
  77. Fakeye T. O. Onyemadu O. (2008). Evaluation of knowledge base of hospital pharmacists and physicians on herbal medicines in Southwestern Nigeria. Pharm. Pract. 6, 88– 92 PMC4141870 25157286
  78. Fang Y. S. Shan D. M. Liu J. W. Xu W. Li C. L. Wu H. Z. Ji G. (2009). Effect of constituents from fructus Aurantii immaturus and radix Paeoniae alba on gastrointestinal movement. Planta Med. 75, 24– 31 10.1055/s-0028-1088342 19016407 · DOI
  79. Farkas D. Shader R. I. von Moltke L. L. Greenblatt D. J. (2010). “Mechanisms and consequences of drug–drug interactions,” in Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing (John Wiley & Sons, Inc.). 10.1002/9780470571224.pse055 · DOI
  80. Fasinu P. Bouic P. J. Rosenkranz B. (2012). Liver-based in vitro technologies for drug biotransformation studies – a review. Curr. Drug Metab. 13, 215– 224 10.2174/138920012798918426 22300020 · DOI
  81. Feltenstein M. W. Lambdin L. C. Ganzera M. Ranjith H. Dharmaratne W. Nanayakkara N. P. Khan I. A. Sufka K. J. (2003). Anxiolytic properties of piper methysticum extract samples and fractions in the chick social–separation–stress procedure. Phytother. Res. 17, 210– 216 10.1002/ptr.1107 12672148 · DOI
  82. Ferguson C. S. Tyndale R. F. (2011). Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol. Sci. 32, 708– 714 10.1016/j.tips.2011.08.005 21975165 PMC3223320 · DOI
  83. Ferrara L. Montesano D. Senatore A. (2001). The distribution of minerals and flavonoids in the tea plant Camellia sinensis. Farmaco 56, 397– 401 10.1016/S0014-827X(01)01104-1 11482766 · DOI
  84. Fugh-Berman A. (2000). Herb-drug interactions. Lancet 355, 134– 138 10.1016/S0140-6736(99)06457-0 10675182 · DOI
  85. Gaillard Y. Pepin G. (2001). Case report: LC–EI-MS determination of veratridine and cevadine in two fatal cases of Veratrum album poisoning. J. Anal. Toxicol. 25, 481– 485 11550825
  86. Galíndez J. S. Lanza A. M. D. Matellano L. F. (2002). Biologically active substances from the genus Scrophularia. Pharm. Biol. 40, 45– 59 10.1076/phbi.40.1.45.5864 · DOI
  87. Gilani A. H. Khan A. U. Raoof M. Ghayur M. N. Siddiqui B. S. Vohra W. Begum S. (2008). Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus niger are mediated through dual blockade of muscarinic receptors and Ca2+ channels. Fundam. Clin. Pharmacol. 22, 87– 99 10.1111/j.1472-8206.2007.00561.x 18251725 · DOI
  88. Gilca M. Gaman L. Panait E. Stoian I. Atanasiu V. (2010). Chelidonium majus – an integrative review: traditional knowledge versus modern findings. Forsch. Komplementmed. 17, 241– 248 10.1159/000321397 20980763 · DOI
  89. Giveon S. M. Liberman N. Klang S. Kahan E. (2004). Are people who use ‘natural drugs’ aware of their potentially harmful side effects and reporting to family physician? Patient Educ. Couns. 53, 5– 11 10.1016/S0738-3991(03)00241-6 15062898 · DOI
  90. Goh S. Y. Loh K. C. (2001). Gynaecomastia and the herbal tonic “dong quai.” Singapore Med. J. 42, 115– 116 11405562
  91. Greeson J. M. Sanford B. Monti D. A. (2001). St. John’s wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology (Berl.) 153, 402– 414 10.1007/s002130000625 11243487 · DOI
  92. Gurley B. J. Gardner S. F. Hubbard M. A. Williams D. K. Gentry W. B. Cui Y. Ang C. Y. (2005a). Clinical assessment of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John’s wort, garlic oil, Panax ginseng, and Ginkgo biloba. Drugs Aging 22, 525– 539 10.2165/00002512-200522060-00006 15974642 PMC1858666 · DOI
  93. Hafner V. Jäger M. Matthée A. K. Ding R. Burhenne J. Haefeli W. E. Mikus G. (2009). Effect of simultaneous induction and inhibition of CYP3A by St John’s wort and ritonavir on CYP3A activity. Clin. Pharmacol. Ther. 87, 191– 196 10.1038/clpt.2009.206 19924124 · DOI
  94. Hamann G. L. Campbell J. D. George C. M. (2011). Warfarin-cranberry juice interaction. Ann. Pharmacother. 45, e17 10.1345/aph.1P517 21364039 · DOI
  95. Hattori T. (2010). Rikkunshito and ghrelin. Int. J. Pept. 2010, pii: 20721287 PMC2915625
  96. He S. M. Li R. Kanwar J. R. Zhou S. F. (2011). Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). Curr. Med. Chem. 18, 439– 481 10.2174/092986711794480131 21143116 · DOI
  97. Henderson L. Yue Q. Y. Bergquist C. Gerden B. Arlett P. (2002). St John’s wort (Hypericum perforatum): drug interactions and clinical outcomes. Br. J. Clin. Pharmacol. 54, 349– 356 10.1046/j.1365-2125.2002.01683.x 12392581 PMC1874438 · DOI
  98. Hiratsuka M. (2011). In vitro assessment of the allelic variants of cytochrome P450. Drug Metab. Pharmacokinet. [Epub online ahead of print]. 22041138
  99. Hojo Y. Echizenya M. Ohkubo T. Shimizu T. (2011). Drug interaction between St John’s wort and zolpidem in healthy subjects. J. Clin. Pharm. Ther. 36, 711– 715 10.1111/j.1365-2710.2010.01223.x 21058968 · DOI
  100. Hokkanen J. Tolonen A. Mattila S. Turpeinen M. (2011). Metabolism of hyperforin, the active constituent of St. John’s wort, in human liver microsomes. Eur. J. Pharm. Sci. 42, 273– 284 10.1016/j.ejps.2010.12.002 21168483 · DOI
  101. Homsy J. King R. Tenywa J. Kyeyune P. Opio A. Balaba D. (2004). Defining minimum standards of practice for incorporating African traditional medicine into HIV/AIDS prevention, care, and support: a regional initiative in eastern and southern Africa. J. Altern. Complement. Med. 10, 905– 910 10.1089/acm.2004.10.905 15650481 · DOI
  102. Howell L. Kochhar K. Saywell R. Jr. Zollinger T. Koehler J. Mandzuk C. Sutton B. Sevilla-Martir J. Allen D. (2006). Use of herbal remedies by Hispanic patients: do they inform their physician? J. Am. Board Fam. Med. 19, 566– 578 10.3122/jabfm.19.6.566 17090790 · DOI
  103. Høyland H. K. (2011). Use of Saint John’s wort against mild depression. Tidsskr. Nor. Laegeforen. 131, 837– 839 10.4045/tidsskr.10.0752 21556089 · DOI
  104. Hsieh M. J. Yen Z. S. Chen S. C. Fang C. C. (2008). Acute cholinergic syndrome following ingestion of contaminated herbal extract. Emerg. Med. J. 25, 781– 782 10.1136/emj.2008.060889 18955628 · DOI
  105. Hu Z. Yang X. Ho P. C. Chan S. Y. Heng P. W. Chan E. Duan W. Koh H. L. Zhou S. (2005). Herb-drug interactions: a literature review. Drugs 65, 1239– 1282 10.2165/00003495-200565090-00005 15916450 · DOI
  106. Huang Z. Xiao B. Wang X. Li Y. Deng H. (2003). Betel nut indulgence as a cause of epilepsy. Seizure 12, 406– 408 10.1016/S1059-1311(02)00377-1 12915088 · DOI
  107. Iqbal M. Sharma S. D. Okazaki Y. Fujisawa M. Okada S. (2003). Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol. Toxicol. 92, 33– 38 10.1034/j.1600-0773.2003.920106.x 12710595 · DOI
  108. Isbrucker R. A. Burdock G. A. (2006). Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul. Toxicol. Pharmacol. 46, 167– 192 10.1016/j.yrtph.2006.06.002 16884839 · DOI
  109. Isnard B. C. Deray G. Baumelou A. Le Quintrec M. Vanherweghem J. L. (2004). Herbs and the kidney. Am. J. Kidney Dis. 44, 1– 11 10.1053/S0272-6386(04)00714-0 15211432 · DOI
  110. Iwamoto M. Kassahun K. Troyer M. D. Hanley W. D. Lu P. Rhoton A. Petry A. S. Ghosh K. Mangin E. DeNoia E. P. Wenning L. A. Stone J. A. Gottesdiener K. M. Wagner J. A. (2008). Lack of a pharmacokinetic effect of raltegravir on midazolam: in vitro/in vivo correlation. J. Clin. Pharmacol. 48, 209– 214 10.1177/0091270007310382 18077730 · DOI
  111. Iwanaga K. Hayashi M. Hamahata Y. Miyazaki M. Shibano M. Taniguchi M. Baba K. Kakemi M. (2010). Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein. Drug Metab. Dispos. 38, 1286– 1294 10.1124/dmd.110.032847 20463004 · DOI
  112. Izzo A. A. (2005). Herb–drug interactions: an overview of the clinical evidence. Fundam. Clin. Pharmacol. 19, 1– 16 10.1111/j.1472-8206.2004.00301.x 15660956 · DOI
  113. Izzo A. I. Sautebin L. Rombola L. Capasso F. (1997). The role of constitutive nitric oxide synthase in senna- and cascara-induced diarrhoea in the rat. Eur. J. Pharmacol. 323, 93– 97 10.1016/S0014-2999(97)00023-X 9105882 · DOI
  114. Jha V. (2010). Herbal medicines and chronic kidney disease. Nephrology (Carlton) 15, 10– 17 10.1111/j.1440-1797.2010.01305.x 20586941 · DOI
  115. Johne A. Schmider J. Brockmöller J. Stadelmann A. M. Störmer E. Bauer S. Scholler G. Langheinrich M. Roots I. (2002). Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John’s wort (Hypericum perforatum). J. Clin. Psychopharmacol. 22, 46– 54 10.1097/00004714-200202000-00008 11799342 · DOI
  116. Kataya H. H. Hamza A. A. Ramadan G. A. Khasawneh M. A. (2011). Effect of licorice extract on the complications of diabetes nephropathy in rats. Drug Chem. Toxicol. 34, 101– 108 10.3109/01480545.2010.510524 21314459 · DOI
  117. Katoh M. Yoshioka Y. Nakagawa N. Yokoi T. (2009). Effects of Japanese herbal medicine, Kampo, on human UGT1A1 activity. Drug Metab. Pharmacokinet. 24, 226– 234 10.2133/dmpk.24.226 19571434 · DOI
  118. Kaufman D. Kelly J. Rosenberg L. Anderson T. E. Mitchell A. A. (2002). Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 287, 37– 44 10.1001/jama.287.3.337 11790213 · DOI · Paper page
  119. Kawahara H. Mitani Y. Nomura M. Nose K. Yoneda A. Hasegawa T. Kubota A. Fukuzawa M. (2009). Impact of rikkunshito, an herbal medicine, on delayed gastric emptying in profoundly handicapped patients. Pediatr. Surg. Int. 25, 987– 990 10.1007/s00383-009-2453-4 19697049 · DOI
  120. Kennedy J. Wang C. Wu C. (2008). Patient disclosure about herb and supplement use among adults in the US. Evid. Based Complement. Alternat. Med. 5, 451– 456 10.1093/ecam/nem045 18955213 PMC2586312 · DOI
  121. Kent U. M. Aviram M. Rosenblat M. Hollenberg P. F. (2002). The Licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9. Drug Metab. Dispos. 30, 709– 715 10.1124/dmd.30.6.709 12019199 · DOI
  122. Kessler R. C. Davis R. B. Foster D. F. Van Rompay M. I. Walters E. E. Wilkey S. A. Kaptchuk T. J. Eisenberg D. M. (2001). Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann. Intern. Med. 135, 262– 268 11511141
  123. Kim B. H. Kim K. P. Lim K. S. Kim J. R. Yoon S. H. Cho J. Y. Lee Y. O. Lee K. H. Jang I. J. Shin S. G. Yu K. S. (2010a). Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers. Clin. Ther. 32, 380– 390 10.1016/j.clinthera.2010.10.001 20206795 · DOI
  124. Kim E. Sy-Cordero A. Graf T. N. Brantley S. J. Paine M. F. Oberlies N. H. (2010b). Isolation and identification of intestinal CYP3A inhibitors from cranberry (Vaccinium macrocarpon) using human intestinal microsomes. Planta Med. 77, 265– 270 10.1055/s-0030-1250259 20717876 PMC3023844 · DOI
  125. Kleiner H. E. Xia X. Sonoda J. Zhang J. Pontius E. Abey J. Evans R. M. Moore D. D. DiGiovanni J. (2008). Effects of naturally occurring coumarins on hepatic drug-metabolizing enzymes in mice. Toxicol. Appl. Pharmacol. 232, 337– 350 10.1016/j.taap.2008.07.004 18692084 PMC2585982 · DOI
  126. Klepser T. B. Doucette W. R. Horton M. R. (2000). Assessment of patients’ perceptions and beliefs regarding herbal therapies. Pharmacotherapy 20, 83– 87 10.1592/phco.20.1.83.34658 10641978 · DOI
  127. Krishna R. Mayer L. D. (2001). Modulation of P-glycoprotein (PGP) mediated multidrug resistance (MDR) using chemosensitizers: recent advances in the design of selective MDR modulators. Curr. Med. Chem. Anticancer Agents 1, 163– 174 10.2174/1568011013354705 12678765 · DOI
  128. Lai M. N. Wang S. M. Chen P. C. Chen Y. Y. Wang J. D. (2010). Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J. Natl. Cancer Inst. 102, 179– 186 10.1093/jnci/djp467 20026811 PMC2815723 · DOI
  129. Laitinen L. Takala E. Vuorela H. Vuorela P. Kaukonen A. M. Marvola M. (2007). Anthranoid laxative influence the absorption of poorly permeable drugs in human intestinal cell culture model (Caco-2). Eur. J. Pharm. Biopharm. 66, 135– 145 10.1016/j.ejpb.2006.09.006 17098405 · DOI
  130. Lala L. G. D’Mello P. M. Naik S. R. (2004). Pharmacokinetic and pharmacodynamic studies on interaction of “Trikatu” with diclofenac sodium. J. Ethnopharmacol. 91, 277– 280 10.1016/j.jep.2003.12.027 15120451 · DOI
  131. Larsen A. K. Escargueil A. E. Skladanowski A. (2000). Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol. Ther. 85, 217– 229 10.1016/S0163-7258(99)00073-X 10739876 · DOI
  132. Lau W. C. Welch T. D. Shields T. Rubenfire M. Tantry U. S. Gurbel P. A. (2011). The effect of St John’s wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity. J. Cardiovasc. Pharmacol. 57, 86– 93 10.1097/FJC.0b013e3181ffe8d0 20980920 · DOI
  133. Lawvere S. Mahoney M. C. (2005). St John’s wort. Am. Fam. Physician 72, 2249– 2254 16342849
  134. Leclercq I. A. Farrell G. C. Field J. Bell D. R. Gonzalez F. J. Robertson G. R. (2000). CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J. Clin. Invest. 105, 1067– 1075 10.1172/JCI8814 10772651 PMC300833 · DOI
  135. Lee J. Y. Duke R. K. Tran V. H. Hook J. M. Duke C. C. (2006). Hyperforin and its analogues inhibit CYP3A4 enzyme activity. Phytochemistry 67, 2550– 6250 10.1016/j.phytochem.2006.05.008 17083953 · DOI
  136. Lewis D. F. V. (2004). 57 varieties: the human cytochromes P450. Pharmacogenomics 5, 305– 318 10.1517/phgs.5.3.305.29827 15102545 · DOI
  137. Lewis J. H. Ahmed M. Shobassy A. Palese C. (2006). Drug-induced liver disease. Curr. Opin. Gastroenterol. 22, 223– 233 10.1097/01.mog.0000218958.40441.fd 16550036 · DOI
  138. Li M. Andrew M. A. Wang J. Salinger D. H. Vicini P. Grady R. W. Phillips B. Shen D. D. Anderson G. D. (2009). Effects of cranberry juice on pharmacokinetics of beta-lactam antibiotics following oral administration. Antimicrob. Agents Chemother. 53, 2725– 2732 10.1128/AAC.00428-09 19398645 PMC2704661 · DOI
  139. Liang Y. Xie P. Chan K. (2004). Quality control of herbal medicines. J. Chromatogr. 812, 53– 70 10.1016/j.jchromb.2004.08.041 15556488 · DOI
  140. Liao H. Ma T. Li Y. Chen J. T. Chang Y. S. (2010). Concurrent use of corticosteroids with Licorice-containing TCM preparations in Taiwan: a National Health Insurance Database Study. J. Altern. Complement. Med. 16, 539– 544 10.1089/acm.2009.0267 20438302 · DOI
  141. Liu C. X. Yi X. L. Si D. Y. Xiao X. F. He X. Li Y. Z. (2011). Herb-drug interactions involving drug metabolizing enzymes and transporters. Curr. Drug Metab. 12, 835– 849 21619518
  142. Luyckx V. A. Naicker S. (2008). Acute kidney injury associated with the use of traditional medicines. Nat. Clin. Pract. Nephrol. 4, 664– 671 10.1038/ncpneuro0950 18838981 · DOI
  143. Ma X. H. Zheng C. J. Han L. Y. Xie B. Jia J. Cao Z. W. Li Y. X. Chen Y. Z. (2009). Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives. Drug Discov. Today 14, 579– 588 10.1016/j.drudis.2009.09.006 19508920 · DOI
  144. Madabushi R. Frank B. Drewelow B. Derendorf H. Butterweck V. (2006). Hyperforin in St. John’s wort drug interactions. Eur. J. Clin. Pharmacol. 62, 225– 233 10.1007/s00228-006-0096-0 16477470 · DOI
  145. Malati C. Y. Robertson S. M. Hunt J. D. Chairez C. Alfaro R. M. Kovacs J. A. Penzak S. R. (2011). Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants. J. Clin. Pharmacol. [Epub ahead of print]. 10.1177/0091270011407194 21646440 PMC3523324 · DOI
  146. Mannel M. (2004). Drug interactions with St John’s wort: mechanisms and clinical implications. Drug Saf. 27, 773– 797 10.2165/00002018-200427110-00003 15350151 · DOI
  147. Marchetti S. Mazzanti R. Beijnen J. H. (2007). Concise review: clinical relevance of drug–drug and herb–drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist 12, 927– 941 10.1634/theoncologist.12-8-927 17766652 · DOI · Paper page
  148. Markell M. S. (2010). “Herbal remedies and the patient with chronic kidney disease,” in Herbal Supplements: Efficacy, Toxicity, Interactions with Western Drugs, and Effects on Clinical Laboratory Tests. 10.1002/9780470910108.ch6 · DOI
  149. Markowitz J. S. DeVane C. L. Chavin K. D. Taylor R. M. Ruan Y. Donovan J. L. (2003a). Effects of garlic (Allium sativun L) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin. Pharmacol. Ther. 74, 170– 177 10.1016/S0009-9236(03)00148-6 12891227 · DOI
  150. Markowitz J. S. Donovan J. L. DeVane C. L. Taylor R. M. Ruan Y. Wang J. S. Chavin K. D. (2003b). Effect of St John’s wort on drug metabolism by induction of cytochrome P450 3A4 Enzyme. JAMA 290, 1500– 1504 10.1001/jama.290.15.2056 13129991 · DOI
  151. Martignoni M. Groothuis G. M. M. de Kanter R. (2006). Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin. Drug Metab. Toxicol. 2, 875– 894 10.1517/17425255.2.6.875 17125407 · DOI · Paper page
  152. Marx J. Pretorius E. Espag W. J. Bester M. J. (2005). Urginea sanguinea: medicinal wonder or death in disguise? Environ. Toxicol. Pharmacol. 20, 26– 34 10.1016/j.etap.2004.09.012 21783564 · DOI
  153. Marzolini C. Paus E. Buclin T. Kim R. B. (2004). Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther. 75, 13– 33 10.1016/j.clpt.2003.11.354 14749689 · DOI
  154. Matsumura T. Arai M. Yonemitsu Y. Maruoka D. Tanaka T. Suzuki T. Yoshikawa M. Imazeki F. Yokosuka O. (2010). The traditional Japanese medicine rikkunshito increases the plasma level of ghrelin in humans and mice. J. Gastroenterol. 45, 300– 307 10.1007/s00535-009-0166-z 19997944 · DOI
  155. Meijerman I. Beijnen J. H. Schellens J. H. M. (2006). Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 11, 742– 752 10.1634/theoncologist.11-7-742 16880233 · DOI
  156. Merino G. Perez M. Real R. Egidom E. Prieto J. G. Alvarez A. I. (2010). In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in BCRP1 mice. Pharm. Res. 27, 2098– 2105 10.1007/s11095-010-0208-5 20607366 · DOI
  157. Methlie P. Husebye E. Hustad S. S. Lien E. A. Løvås K. (2011). Grapefruit juice and liquorice increase cortisol availability in patients with Addison’s disease. Eur. J. Endocrinol. 165, 761– 769 10.1530/EJE-11-0518 21896619 · DOI · Paper page
  158. Mochiki E. Yanai M. Ohno T. Kuwano H. (2010). The effect of traditional Japanese medicine (Kampo) on gastrointestinal function. Surg. Today 40, 1105– 1111 10.1007/s00595-010-4388-8 21110152 · DOI
  159. Mohamed M. E. Frye R. F. (2010). Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids. Drug Metab. Dispos. 38, 270– 275 10.1124/dmd.109.030080 19889883 · DOI
  160. Mohamed M. E. Frye R. F. (2011a). Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies. Planta Med. 77, 311– 321 10.1055/s-0031-1282487 21049395 · DOI
  161. Mohamed M. E. Frye R. F. (2011b). Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities. Drug Metab. Dispos. 39, 1522– 1528 10.1124/dmd.111.039602 21632963 PMC3164271 · DOI
  162. Mohammed A. M. I. Jiang X. Williams K. M. Day R. O. Roufogalis B. D. Liauw W. S. Xu H. McLachlan A. J. (2008). Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br. J. Pharmacol. 154, 1691– 1700 10.1038/bjp.2008.210 18516070 PMC2518459 · DOI
  163. Mok D. K. W. Chau F. (2006). Chemical information of Chinese medicines: a challenge to chemist. Chemometrics Intell. Lab. Syst. 82, 210– 217 10.1016/j.chemolab.2005.05.006 · DOI
  164. Moorthy R. Prabhu K. M. Murthy P. S. (2010). Mechanism of anti-diabetic action, efficacy and safety profile of GII purified from fenugreek (Trigonella foenum-graceum Linn.) seeds in diabetic animals. Indian J. Exp. Biol. 48, 1119– 1122 21117452
  165. Mu Y. Zhang J. Zhang S. Zhou H. H. Toma D. Ren S. Huang L. Yaramus M. Baum A. Venkataramanan R. Xie W. (2006). Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J. Pharmacol. Exp. Ther. 316, 1369– 1377 10.1124/jpet.105.094342 16267138 · DOI
  166. Mukhtar H. M. Ansari S. H. Bhat Z. A. Naved T. (2006). Antihyperglycemic activity of Cyamopsis tetragonoloba. Beans on blood glucose levels in alloxan-induced diabetic rats. Pharm. Biol. 44, 10– 13 10.1080/13880200500509025 15623233 · DOI
  167. Munday R. Munday C. M. (1999). Low doses of diallyl disulfide, a compound derived from garlic, increase tissue activities of quinone reductase and glutathione transferase in the gastrointestinal tract of the rat. Nutr. Cancer 34, 42– 48 10.1207/S15327914NC340106 10453440 · DOI
  168. Murakami Y. Tanaka T. Murakami H. Tsujimoto M. Ohtani H. Sawada Y. (2006). Pharmacokinetic modelling of the interaction between St John’s wort and ciclosporin A. Br. J. Clin. Pharmacol. 61, 671– 676 10.1111/j.1365-2125.2006.02606.x 16722827 PMC1885115 · DOI
  169. Nabekura T. Yamaki T. Hiroi T. Ueno K. Kitagawa S. (2010). Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals. Pharmacol. Res. 61, 259– 263 10.1016/j.phrs.2009.11.010 19944162 · DOI
  170. Nagai M. Fukamachi T. Tsujimoto M. Ogura K. Hiratsuka A. Ohtani H. Hori S. Sawada Y. (2009). Inhibitory effects of herbal extracts on the activity of human sulfotransferase isoform sulfotransferase 1A3 (SULT1A3). Biol. Pharm. Bull. 32, 105– 159 10.1248/bpb.32.1594 19122289 · DOI
  171. Nakagawa N. Katoh M. Yoshioka Y. Nakajima M. Yokoi T. (2009). Inhibitory effects of Kampo medicine on human UGT2B7 activity. Drug Metab. Pharmacokinet. 24, 490– 499 10.2133/dmpk.24.490 20045984 · DOI
  172. Nebert D. W. Russell D. W. (2002). Clinical importance of the cytochrome P450. Lancet 360, 1155– 1162 10.1016/S0140-6736(02)11203-7 12387968 · DOI
  173. Ni W. Zhang X. Wang B. Chen Y. Han H. Fan Y. Zhou Y. Tai G. (2010). Antitumor activities and immunomodulatory effects of ginseng neutral polysaccharides in combination with 5-fluorouracil. J. Med. Food 13, 270– 277 10.1089/jmf.2009.1119 20132044 · DOI
  174. Nieminen T. H. Hagelberg N. M. Saari T. I. Neuvonen M. Laine K. Neuvonen P. J. Olkkola K. T. (2010). St John’s wort greatly reduces the concentrations of oral oxycodone. Eur. J. Pain 14, 854– 859 10.1016/j.ejpain.2009.12.007 20106684 · DOI
  175. Nishikawa M. Ariyoshi N. Kotani A. Ishii I. Nakamura H. Nakasa H. Ida M. Nakamura H. Kimura N. Kimura M. Hasegawa A. Kusu F. Ohmori S. Nakazawa K. Kitada M. (2004). Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab. Pharmacokinet. 19, 280– 289 10.2133/dmpk.19.280 15499196 · DOI
  176. Nivitabishekam S. N. Asad M. Prasad V. S. (2009). Pharmacodynamic interaction of Momordica charantia with rosiglitazone in rats. Chem. Biol. Interact. 177, 247– 253 10.1016/j.cbi.2008.09.034 18983991 · DOI
  177. Norlin M. Wikvall K. (2007). Enzymes in the conversion of cholesterol into bile acids. Curr. Mol. Med. 7, 199– 218 10.2174/156652407780059168 17346171 · DOI
  178. Nowack R. (2008). Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John’s wort – and beyond! Nephrology (Carlton) 13, 337– 347 10.1111/j.1440-1797.2008.00940.x 18363644 · DOI
  179. Nutescu E. A. Shapiro N. L. Ibrahim S. West P. (2006). Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin. Drug Saf. 5, 433– 451 10.1517/14740338.5.3.433 16610971 · DOI
  180. Okada K. Shoda J. Kano M. Suzuki S. Ohtake N. Yamamoto M. Takahashi H. Utsunomiya H. Oda K. Sato K. Watanabe A. Ishii T. Itoh K. Yamamoto M. Yokoi T. Yoshizato K. Sugiyama Y. Suzuki H. (2007). Inchinkoto, a herbal medicine and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat liver. Am. J. Physiol. 292, G1450– G1463 17038627
  181. Oluwatuyi M. Kaatz G. W. Gibbons S. (2004). Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry 65, 3249– 3254 10.1016/j.phytochem.2004.10.009 15561190 · DOI
  182. Ono A. E. Owo O. I. Itam E. H. Konya R. S. (2000). Blood pressure depression by the fruit juice of Carica papaya (L.) in renal and DOCA-induced hypertension in the rat. Phytother. Res. 14, 235– 239 10.1002/1099-1573(200006)14:4<235::AID-PTR574>3.0.CO;2-G 10861964 · DOI
  183. Ono S. Hatanaka T. Hotta H. Satoh T. Gonzalez F. J. Tsutsui M. (1996). Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450 and human liver microsomes. Xenobiotica 26, 681– 693 10.3109/00498259609046742 8819299 · DOI
  184. Ozcakir A. Sadikoglu G. Bayram N. Mazicioglu M. M. Bilgel N. Beyhan I. (2007). Turkish general practitioners and complementary/alternative medicine. J. Altern. Complement. Med. 13, 1007– 1010 10.1089/acm.2007.7168 18047448 · DOI
  185. Paine M. F. Widmer W. W. Pusek S. N. Beavers K. L. Criss A. B. Snyder J. Watkins P. B. (2008). Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. Am. J. Clin. Nutr. 87, 863– 871 18400708
  186. Pal D. Mitra A. K. (2006). MDR- and CYP3A4-mediated drug–herbal interactions. Life Sci. 78, 2131– 2145 10.1016/j.lfs.2005.12.010 16442130 · DOI
  187. Palombo E. A. (2006). Phytochemicals from traditional medicinal plants used in the treatment of diarrhoea: modes of action and effects on intestinal function. Phytother. Res. 20, 717– 724 10.1002/ptr.1907 16619336 · DOI
  188. Patanasethanont D. Nagai J. Yumoto R. Murakami T. Sutthanut K. Sripanidkulchai B. O. Yenjai C. Takano M. (2007). Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function. J. Pharm. Sci. 96, 223– 233 10.1002/jps.20769 17031860 · DOI
  189. Patel M. Bessong P. Liu H. (2011). Traditional medicines, HIV, and related infections: workshop 2C. Adv. Dent. Res. 23, 159– 164 10.1177/0022034511400077 21441498 · DOI
  190. Patsalos P. Perucca E. (2003). Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet 2, 4734– 4781 12878435
  191. Pavek P. Dvorak Z. (2008). Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr. Drug Metab. 9, 129– 143 10.2174/138920008783571774 18288955 · DOI
  192. Perucca E. (2006). Clinically relevant drug interactions with antiepileptic drugs. Br. J. Clin. Pharmacol. 61, 246– 255 10.1111/j.1365-2125.2005.02529.x 16487217 PMC1885026 · DOI
  193. Pierard S. Coche J. C. Lanthier P. Dekoninck X. Lanthier N. Rahier J. Geubel A. P. (2009). Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution. Eur. J. Gastroenterol. Hepatol. 21, 941– 945 10.1097/MEG.0b013e3283155451 19404202 · DOI
  194. Qi Q. H. Wang J. Liang G. G. Wu X. Z. (2007). Da-Cheng-Qi-Tang promotes the recovery of gastrointestinal motility after abdominal surgery in humans. Dig. Dis. Sci. 52, 1562– 1570 10.1007/s10620-007-9751-2 17415634 · DOI
  195. Quintieri L. Palatini P. Nassi A. Ruzza P. Floreani M. (2008). Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP3A4 and CYP3A5 enzymes. Biochem. Pharmacol. 75, 1426– 1437 10.1016/j.bcp.2007.11.012 18191104 · DOI
  196. Rannug U. Agurell E. Rannug A. Cederberg H. (2006). Certain tryptophan photoproducts are inhibitors of cytochrome P450-dependent mutagenicity. Environ. Mol. Mutagen. 20, 289– 296 10.1002/em.2850200407 1330548 · DOI
  197. Roberts D. Flanagan P. (2011). Case report: cranberry juice and warfarin. Home Healthc. Nurse 29, 92– 97 10.1097/NHH.0b013e3182079970 21301274 · DOI
  198. Roby C. A. Anderson G. Kantor E. Dryer D. A. Burstein A. H. (2000). St John’s wort: effect on CYP3A4 activity. Clin. Pharmacol. Ther. 67, 451– 457 10.1067/mcp.2000.106793 10824623 · DOI
  199. Rogers K. L. Grice I. D. Griffiths L. R. (2000). Inhibition of platelet aggregation and 5-HT release by extracts of Australian plants used traditionally as headache treatments. Eur. J. Pharm. Sci. 9, 355– 363 10.1016/S0928-0987(99)00074-3 10664475 · DOI
  200. Rostami-Hodjegan A. Tucker G. T. (2007). Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nat. Rev. Drug Discov. 6, 140– 148 10.1038/nrd2173 17268485 · DOI

200 of 262 shown

Cited by

Sorted by citations

Metadata

Authors
Fasinu, P. S., Bouic, P. J., & Rosenkranz, B.
Venue
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Published
2012
Volume
3
ISSN
1663-9812
DOI
10.3389/fphar.2012.00069
PMC
PMC3339338
Cited by
221
References
9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review